BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

512 related articles for article (PubMed ID: 12847088)

  • 1. Regulated splicing of the fibronectin EDA exon is essential for proper skin wound healing and normal lifespan.
    Muro AF; Chauhan AK; Gajovic S; Iaconcig A; Porro F; Stanta G; Baralle FE
    J Cell Biol; 2003 Jul; 162(1):149-60. PubMed ID: 12847088
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impaired motor coordination in mice lacking the EDA exon of the fibronectin gene.
    Chauhan AK; Moretti FA; Iaconcig A; Baralle FE; Muro AF
    Behav Brain Res; 2005 Jun; 161(1):31-8. PubMed ID: 15904707
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Age-dependent differential expression of fibronectin variants in skin and airway mucosal wounds.
    Li-Korotky HS; Hebda PA; Lo CY; Dohar JE
    Arch Otolaryngol Head Neck Surg; 2007 Sep; 133(9):919-24. PubMed ID: 17875859
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alternatively spliced isoforms of fibronectin in immune-mediated glomerulosclerosis: the role of TGFbeta and IL-4.
    Baelde HJ; Eikmans M; van Vliet AI; Bergijk EC; de Heer E; Bruijn JA
    J Pathol; 2004 Nov; 204(3):248-57. PubMed ID: 15372454
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of EDA+ and EDB+ fibronectin splice variants in bone.
    Kilian O; Dahse R; Alt V; Zardi L; Rosenhahn J; Exner U; Battmann A; Schnettler R; Kosmehl H
    Bone; 2004 Dec; 35(6):1334-45. PubMed ID: 15589214
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fibronectin mRNA alternative splicing is temporally and spatially regulated during chondrogenesis in vivo and in vitro.
    Gehris AL; Oberlender SA; Shepley KJ; Tuan RS; Bennett VD
    Dev Dyn; 1996 Jun; 206(2):219-30. PubMed ID: 8725289
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mice lacking the EDB segment of fibronectin develop normally but exhibit reduced cell growth and fibronectin matrix assembly in vitro.
    Fukuda T; Yoshida N; Kataoka Y; Manabe R; Mizuno-Horikawa Y; Sato M; Kuriyama K; Yasui N; Sekiguchi K
    Cancer Res; 2002 Oct; 62(19):5603-10. PubMed ID: 12359774
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The relationship between expression of FN in human skin injury and early injury time].
    Xue AM; Zhao ZQ; Shen YW
    Fa Yi Xue Za Zhi; 2003; 19(3):140-2. PubMed ID: 13677314
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Absence of regulated splicing of fibronectin EDA exon reduces atherosclerosis in mice.
    Babaev VR; Porro F; Linton MF; Fazio S; Baralle FE; Muro AF
    Atherosclerosis; 2008 Apr; 197(2):534-40. PubMed ID: 17897651
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alternative splicing of fibronectin mRNAs in chondrosarcoma cells: role of far upstream intron sequences.
    Flanagan M; Liang H; Norton PA
    J Cell Biochem; 2003 Nov; 90(4):709-18. PubMed ID: 14587027
    [TBL] [Abstract][Full Text] [Related]  

  • 11. mRNA expression and protein distribution of fibronectin splice variants and high-molecular weight tenascin-C in different phases of human fracture healing.
    Kilian O; Dahse R; Alt V; Zardi L; Hentschel J; Schnettler R; Kosmehl H
    Calcif Tissue Int; 2008 Aug; 83(2):101-11. PubMed ID: 18663401
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evolutionary connections between coding and splicing regulatory regions in the fibronectin EDA exon.
    Zago P; Buratti E; Stuani C; Baralle FE
    J Mol Biol; 2011 Aug; 411(1):1-15. PubMed ID: 21663748
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transforming growth factor-beta1 (TGF-beta1) regulates ATDC5 chondrogenic differentiation and fibronectin isoform expression.
    Han F; Adams CS; Tao Z; Williams CJ; Zaka R; Tuan RS; Norton PA; Hickok NJ
    J Cell Biochem; 2005 Jul; 95(4):750-62. PubMed ID: 15832361
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alternative splicing of fibronectin: a mouse model demonstrates the identity of in vitro and in vivo systems and the processing autonomy of regulated exons in adult mice.
    Chauhan AK; Iaconcig A; Baralle FE; Muro AF
    Gene; 2004 Jan; 324():55-63. PubMed ID: 14693371
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of fibronectin expression and splicing in migrating epithelial cells: migrating MDCK cells produce a lesser amount of, but more active, fibronectin.
    Inoue T; Nabeshima K; Shimao Y; Meng JY; Koono M
    Biochem Biophys Res Commun; 2001 Feb; 280(5):1262-8. PubMed ID: 11162664
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The exon 8-containing prosaposin gene splice variant is dispensable for mouse development, lysosomal function, and secretion.
    Cohen T; Auerbach W; Ravid L; Bodennec J; Fein A; Futerman AH; Joyner AL; Horowitz M
    Mol Cell Biol; 2005 Mar; 25(6):2431-40. PubMed ID: 15743835
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The cytochrome P450 aromatase lacking exon 5 is associated with a phenotype of nonclassic aromatase deficiency and is also present in normal human steroidogenic tissues.
    Pepe CM; Saraco NI; Baquedano MS; Guercio G; Vaiani E; Marino R; Pandey AV; Flück CE; Rivarola MA; Belgorosky A
    Clin Endocrinol (Oxf); 2007 Nov; 67(5):698-705. PubMed ID: 17608756
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of three mouse mu-opioid receptor (MOR) gene (Oprm1) splice variants containing a newly identified alternatively spliced exon.
    Doyle GA; Rebecca Sheng X; Lin SS; Press DM; Grice DE; Buono RJ; Ferraro TN; Berrettini WH
    Gene; 2007 Feb; 388(1-2):135-47. PubMed ID: 17156941
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acetylcholinesterase (AChE) gene modification in transgenic animals: functional consequences of selected exon and regulatory region deletion.
    Camp S; Zhang L; Marquez M; de la Torre B; Long JM; Bucht G; Taylor P
    Chem Biol Interact; 2005 Dec; 157-158():79-86. PubMed ID: 16289062
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dynamic balance between activation and repression regulates pre-mRNA alternative splicing during heart development.
    Ladd AN; Stenberg MG; Swanson MS; Cooper TA
    Dev Dyn; 2005 Jul; 233(3):783-93. PubMed ID: 15830352
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.